Literature DB >> 15651520

Osler-Weber-Rendu disease--unexpected complication following excision of splenic aneurysm--a case report.

Mohamad Bilal Delvi1, Shuja Khan-Ghori, Mussaid M S Al-Salman, Mohamad Said Maani Takrouri.   

Abstract

Osler-Weber-Rendu disease is an autosomal dominant disease, sometimes known as hereditary hemorrhagic telangiectasia (HHT) with a family history. It is a rare disease and there are no records of families with inheritance lineage in Riyadh. We experienced an anesthetic management of a 28-yr-old woman with Osler-Weber-Rendu disease. She was diagnosed to have splenic aneurysm and was scheduled for excision of splenic aneurysm. A chest X-ray revealed pulmonary arterio-venous malformation all over the lungs. The anesthesia and surgery went deliberately smooth with selective period of Intensive Care admission. In the intermediate post operative period, however, she was diagnosed as having pleural effusion. A chest drain was inserted as an emergency, but the patient developed tension pneumothorax, which necessitated resuscitation and readmission to Intensive Care Unit. Lung atelactasis was diagnosed. Attendance by qualified surgical night staff, communication, vigilance and consultations are as important as the proper management of such rare cases.

Entities:  

Mesh:

Year:  2004        PMID: 15651520

Source DB:  PubMed          Journal:  Middle East J Anaesthesiol        ISSN: 0544-0440


  2 in total

1.  Pancytopenia in a Patient with Rendu-Osler-Weber Syndrome and Uncommon Vascular Abnormalities.

Authors:  Nicolò Binello; Antonio Gasbarrini; Eleonora Gaetani
Journal:  Case Rep Hematol       Date:  2016-10-10

2.  Higher prevalence of splenic artery aneurysms in hereditary hemorrhagic telangiectasia: Vascular implications and risk factors.

Authors:  Jacques Sellier; Carma Karam; Alain Beauchet; Axel Dallongeville; Stephen Binsse; Sandra Blivet; Isabelle Bourgault-Villada; Philippe Charron; Thierry Chinet; Mélanie Eyries; Carole Fagnou; Jérome Lesniak; Gilles Lesur; Jérome Lucas; Agnès Nicod-Tran; Augustin Ozanne; Aurélien Palmyre; Florent Soubrier; Mostafa El Hajjam; Pascal Lacombe
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.